SavedAdd your journal

Journals / GORM:Gynecology Obstetrics & Reproductive Medicine / 2015 / Cilt: 21 - Sayı: 3

Preeaklampsi için Yeni Yaklaşımlar: Literatürün Gözden Geçirilmesi

New Approaches for Preeclampsia: Review of the Literature

Emel Ebru ÖZÇİMEN
Pages
174–176
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Hypertensionin pregnancy carries risk for future in cardiovascular diseases

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Preeclampsia is an important cause of maternal death and complicate 5-10% of pregnancies.
📊
Key Findings & Data:The causeinvolves inadequate cytotrophoblastic invasion of the myometrium and maternal endothelial dysfunction.Preeclamptic women should be monitored and definitive therapy is delivery of the fetus.
💡
Conclusion & Impact:Hypertensionin pregnancy carries risk for future in cardiovascular diseases
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Preeclampsia is an important cause of maternal death and complicate 5-10% of pregnancies. The causeinvolves inadequate cytotrophoblastic invasion of the myometrium and maternal endothelial dysfunction.Preeclamptic women should be monitored and definitive therapy is delivery of the fetus. Hypertensionin pregnancy carries risk for future in cardiovascular diseases

Özet

Preeklampsi, gebeliklerin %5-10'unda görülen, maternal ölümlerin önemli bir nedenidir. Sebep, miyometriyuma sitotrofoblastik invazyonun yetersiz olması ve maternal endotelyal disfonksiyondur. Preeklamptik kadın monitörize edilmeli ve kesin tedavi fetüsün doğurtulmasıdır. Gebelikteki hipertansiyon, gelecekte kardiyovasküler hastalıklar açısından risk taşımaktadır

🔖

Cite This Article

ÖZÇİMEN, E. E. (2015). Preeaklampsi için Yeni Yaklaşımlar: Literatürün Gözden Geçirilmesi. GORM:Gynecology Obstetrics & Reproductive Medicine, Cilt: 21 - Sayı: 3, 174–176. https://ajindex.com/articles/197457

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Amanda RV, Leslie SC. Hypertension in pregnancy. Curr Atheroscler Rep 2014;16:395-8. American College of Obstetricians and Gynecologists. Hypertension in pregnancy. http://www.acog.org/ Resources and publications/Task Force and Work Group Reports/2013. 176 Özçimen EE. Mattar F, Sibai BM. Eclampsia VIII. Risk factors for ma- ternal morbidity. Am J Obstet Gynecol 2000;182(2):307- 12. Carty DM, Delles C, Dominiczak AF. Novel biomarkers for predicting preeclampsia. Trends Cardiovasc Med 2008;18(5):186-94.
  2. Levine RJ, Lam C, Qian C, Yu KF, Maynard SE, Sachs BP, et al. Soluble endoglin and other circulating antian- giogenic factors in preeclampsia. N Eng J Med 2006; 355(10):992-1005.
  3. Yu CKH, Smith GCS, Papageorghiou AT, Cacho AM, Nicolaides KH. An integrated model fort he prediction of preeclampsia using maternal factors and uterine artery Doppler velocimetry in unselected low risk women. Am J Obstet Gynecol 2005;193(2):429-36.
  4. Rebelo I, Bernardes J. Preeclampsia prediction and man- agement. Obstet Gynecol Inter 2014; 2 The American College of Obstetricians and Gynecologists Committee on Obstetric Practice Society for maternal- Fetal Medicine 2013;122(3):727-8. Chronic hypertension in pregnancy. Practice bulletin. Am Coll Obstet Gynecol 2012;125:1-12.
  5. Magee LA, Helewa M, Moutquin J-M, von Dadelszen P. Diagnosis, evaluation, and management of the hyperten- sive disorders of pregnancy. J Obstet Gynecol Can 2008; 30(3 Suppl): S1-S48. Homer CS, Brown MA, Mangos G, Davis GK. Non-pro- teinuric pre-eclampsia: a novel risk indicator in women with gestational hypertension. J Hypertens 2008;26(2): 295-302.
  6. Pettit F, Brown MA. The management of pre-eclampsia: what we think we know. Eur J Obstet Gynecol Reprod Biol 2012;160(1):6-12.
  7. Vermillion ST, Scardo JA, Newman RB, Chauhan SP. A randomized, double-blind trial of oral nifedipine and intra-venous labetolol in hypertensive emergencies of pregnancy. Am J Obstet Gynecol 1999;181:858-861.
  8. Raheem IA, Saaid R, Omar SZ, Tan PC. Oral nifedipine versus intravenous labetolol for acute blood pressure con- trol in hypertensive emergencies of pregnancy: a ran- domised trial. BJOG 2012;119:78-85.
  9. Shekhar S, Sharma C, Thakur S, Verma S. Oral nifedipine or intravenous labetolol for hypertensive emergency in pregnancy: a randomized controlled trial. Obstet Gynecol 2013;122:1057-63. Snydal S. Major changes in diagnosis and management of preeclampsia. J Midwifery Women's Health 2014;59(6): 596-605.